Researchers develop new drug for aggressive leukemias
UF researchers have created a drug that effectively kills aggressive leukemia cells by targeting two proteins that promote the cancer’s growth.
Posted in
News
Dr. Nathan Seligson named 2026 Online Teacher of the Year
The clinical associate professor teaches two virtual courses on precision medicine and oncology.
Dr. Nathan Seligson promoted to clinical associate professor
Dr. Seligson's appointment became official on July 1.
Dr. Larisa Cavallari appears in live TV interview with News4Jax
Dr. Larisa Cavallari joined News4JAX TV to discuss a new clinical trial focused on chronic acid reflux.
UF Health Jacksonville trial explores DNA-guided treatment for acid reflux
The study involving UF College of Pharmacy researchers will be the first to examine whether genotype-guided dosing of proton pump inhibitor medications can improve treatment outcomes for erosive esophagitis.
Dr. Maddie Norris wins Innovation in Pharmacogenomics Teaching Award from AACP
Norris co-directs the Clinical Pharmacogenomics and Precision Medicine Online Graduate Program.
New AI Partnership and Innovation Hub poised to transform the UF College of Pharmacy
A new hub at the UF College of Pharmacy will centralize the college’s diverse AI efforts.
Pharmacogenetic testing must become routine, UF Health researchers say
A group of UF Health researchers wrote a commentary for the Journal of the American Heart Association, published May 6.
Dr. Larisa Cavallari elected fellow of the American Heart Association
American Heart Association fellowships are awarded to physicians, scientists and other health care professionals whose scientific and professional accomplishments contribute to the organization’s mission and improve human health.
Springer Nature blog highlights UF research advancing understanding of CD33-negative AML
The blog series highlights how an interdisciplinary research collaboration involving Dr. Jatinder Lamba's lab led to the identification of a rare genomic phenomenon underlying CD33-negative AML.
